VISTAGEN THERAPEUTICS INC (VTGN) Stock Income Statement
NASDAQ:VTGN - US92840H4002 - Common Stock
3.03 USD
-0.14 (-4.42%)
3 USD
-0.03 (-0.99%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 486.00K | 1.06M | -230.00K | 1.11M | 1.09M | |||
| Gross Profit | N/A | N/A | N/A | 1.11M | 1.09M | |||
| Operating Expenses | 56.46M | 34.09M | 59.04M | 48.89M | 19.02M | |||
| Research and Development | 39.38M | 20.02M | 44.28M | 35.31M | 12.41M | |||
| Selling, General, and Administrative Expenses | 17.08M | 14.06M | 14.66M | 13.48M | 6.55M | |||
| Operating Income | -55.97M | -33.02M | -59.27M | -47.78M | -17.93M | |||
| Interest Income/Expense | 4.56M | 3.35M | 30.00K | 20.00K | 0.00 | |||
| Other Income/Expense | 5.00K | 312.00K | N/A | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -51.41M | -29.36M | -59.24M | -47.76M | -17.93M | |||
| Income Tax | 7.00K | 4.00K | 10.00K | 0.00 | 0.00 | |||
| Net Income | -51.42M | -29.36M | -59.25M | -48.71M | -42.32M | |||
| EBITDA | -55.34M | -32.45M | -59.14M | -47.63M | -17.81M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.67 | -1.52 | -8.51 | -7.38 | -14.74 | |||
| Non GAAP EPS | -1.66 | N/A | -8.65 | -2.86 | -0.39 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 100.00% | 100.00% | |||
| Profit Margin | -10579.84% | -2759.59% | 25760.87% | -4388.29% | -3882.57% | |||
| Operating Profit Margin | -11517.08% | -3103.48% | 25769.57% | -4304.50% | -1644.95% | |||
All data in USD